Serum PAD-activity: Risk Factor in Development and Novel Biomarker in Rheumatoid Arthritis

2016/23/B/NZ5/01469

Keywords

Descriptors

  • NZ5_3: Patogeneza chorób człowieka
  • NZ5_5: Diagnostyka chorób człowieka
  • NZ5_7: Leczenie chorób człowieka

Panel

NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr hab. Piotr Mateusz Mydel

Number of co-investigators in the project: 4

Call

OPUS 12 – announced on 2016-09-15

Amount awarded
1 735 600 PLN
Project start date
2017-08-04
Project end date
2021-08-03
Project duration
48 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Equipment purchased [PL]

  1. Specjalistyczny komputer przenośny typu laptop..
  2. System do chromatografii AKTAStart. Cost: 82 000 PLN

Information in the final report

Publication in academic press/journals (5)

  1. Impact of Porphyromonas gingivalis Peptidylarginine Deiminase on Bacterial Biofilm Formation, Epithelial Cell Invasion, and Epithelial Cell Transcriptional Landscape

    Authors:
    Aliko A, Kamińska M, Bergum B, Gawron K, Benedyk M, Lamont R, Malicki S, Delaleu N, Potempa J, Mydel P
    Academic press:
    Scientific Reports (year: 2018, volume: 8 (1), pages: NA), Publisher: Nature Publishing Group
    Status:
    Published
    DOI:
    10.1038/s41598-018-32603-y. – link to the publication
  2. Peptidylarginine deiminase 4 (PAD4) activity in early rheumatoid arthritis

    Authors:
    Jonsson MK, Kantyka, Falkowski K, Aliko A, Aga AB, Lillegraven S, Sexton J, Fevang BT, Mydel P, Haavardsholm EA
    Academic press:
    Scandinavian Journal of Immunology (year: 2019, volume: Sep 23:1-9, pages: 46031), Publisher: Wiley
    Status:
    Published
    DOI:
    10.1080/03009742.2019. – link to the publication
  3. Effects of statins on multispecies oral biofilm identify simvastatin as a drug candidate targeting Porphyromonas gingivalis

    Authors:
    Kaminska M, Aliko A., Hellvard A., Bielecka E., Binder V., Marczyk A., Potempa J., Delaleu N., Kantyka T., Mydel P.
    Academic press:
    Journal of Periodontology (year: 2018, volume: 2018;00:1–10, pages: NA), Publisher: Wiley
    Status:
    Published
    DOI:
    10.1002/JPER.18-0179 – link to the publication
  4. Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor

    Authors:
    Aliko A, Kamińska M, Falkowski K, Bielecka E, Benedyk-Machaczka M, Malicki S, Kozieł J, Wong A, Bryzek D, Kantyka T and Mydel P
    Academic press:
    International Journal of Molecular Sciences (year: 2019, volume: 20(9), 2174, pages: 20(9), 2174), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms20092174 – link to the publication
  5. Development of a novel, high-affinity ssDNA trypsin inhibitor

    Authors:
    Malicki S, Ksiazek M, Majewski P, Pecak A, Mydel P, Grudnik P, Dubin G
    Academic press:
    Journal of Enzyme Inhibition and Medicinal Chemistry (year: 2019, volume: 34(1):638-643, pages: 638-643), Publisher: Taylor & Francis
    Status:
    Published
    DOI:
    10.1080/14756366.2019.1569648 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski